跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HUMIRA adalimumab 80 mg/0.8 mL injection solution pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HUMIRA adalimumab 80 mg/0.8 mL injection solution pre-filled syringe
Approved
STANDARD
HUMIRA adalimumab 80 mg/0.8 mL injection solution pre-filled syringe
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
8a54a5ecda727960
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
8a54a5ecda727960
Product Name
HUMIRA adalimumab 80 mg/0.8 mL injection solution pre-filled syringe
Artg Id
292934
Artg Name
HUMIRA adalimumab 80 mg/0.8 mL injection solution pre-filled syringe
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2018-01-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01077-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03779-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
8a54a5ecda727960
Type
Standard
Back to TGA Approvals